{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:45:57Z","timestamp":1780580757185,"version":"3.54.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1124\/dmd.32.1.28","type":"journal-article","created":{"date-parts":[[2004,1,6]],"date-time":"2004-01-06T20:57:43Z","timestamp":1073422663000},"page":"28-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["IN VITRO METABOLISM OF HYPERFORIN IN RAT LIVER MICROSOMAL SYSTEMS"],"prefix":"10.1016","volume":"32","author":[{"given":"Yanyan","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina Y.W.","family":"Ang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Beger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Heinze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Leakey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.32.1.28_bib1","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0006-2952(02)01387-4","article-title":"Hyperforin is a dual inhibitor of cyclooxygenases-1 and 5-lipoxygenase.","volume":"64","author":"Albert","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.32.1.28_bib2","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/jaoac\/85.6.1360","article-title":"Determination of St. John\u2019s wort components in dietary supplements and functional foods by liquid chromatography.","volume":"85","author":"Ang","year":"2002","journal-title":"J AOAC Int"},{"key":"10.1124\/dmd.32.1.28_bib3","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1063\/1.432450","article-title":"Two-dimensional spectroscopy. Application to nuclear magnetic resonance.","volume":"64","author":"Aue","year":"1976","journal-title":"J Chem Phys"},{"key":"10.1124\/dmd.32.1.28_bib4","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1345\/aph.10088","article-title":"Drug interaction between St. John\u2019s wort and cyclosporine.","volume":"34","author":"Barone","year":"2000","journal-title":"Ann Pharmacother"},{"key":"10.1124\/dmd.32.1.28_bib5","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1021\/ja00268a061","article-title":"1H and 13C assignments from sensitivity-enhanced detection of heteronuclear multiple-bond connectivity by 2D multiple quantum NMR.","volume":"108","author":"Bax","year":"1986","journal-title":"J Am Chem Soc"},{"key":"10.1124\/dmd.32.1.28_bib6","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1345\/aph.18026","article-title":"Neuropharmacology of St. John\u2019s wort (Hypericum).","volume":"32","author":"Bennett","year":"1998","journal-title":"Ann Pharmacother"},{"issue":"Suppl","key":"10.1124\/dmd.32.1.28_bib7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1055\/s-2007-979344","article-title":"Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers.","volume":"31","author":"Biber","year":"1998","journal-title":"Pharmacopsychiatry"},{"key":"10.1124\/dmd.32.1.28_bib8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0378-5173(00)00660-8","article-title":"Evaluation of chemical stability of St. John\u2019s wort commercial extract and some preparations.","volume":"213","author":"Bilia","year":"2001","journal-title":"Int J Pharm"},{"key":"10.1124\/dmd.32.1.28_bib9","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0165-6147(00)01716-8","article-title":"St. John\u2019s wort: Prozac from the plant kingdom.","volume":"22","author":"Carlo","year":"2001","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/dmd.32.1.28_bib10","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0024-3205(98)00299-9","article-title":"Hyperforin as a possible antidepressant component of hypericum extracts.","volume":"63","author":"Chatterjee","year":"1998","journal-title":"Life Sci"},{"issue":"Suppl","key":"10.1124\/dmd.32.1.28_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-2007-979340","article-title":"Antidepressant activity of Hypericum perforatum and hyperforin: the neglected possibility.","volume":"31","author":"Chatterjee","year":"1998","journal-title":"Pharmacopsychiatry"},{"key":"10.1124\/dmd.32.1.28_bib12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/jbt.2570100604","article-title":"Differential regulation of cytochrome P450 3A and P450 3A2 in rat liver following dexamethasone treatment.","volume":"10","author":"Choudhuri","year":"1995","journal-title":"J Biochem Toxicol"},{"key":"10.1124\/dmd.32.1.28_bib13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1570-0232(02)00439-7","article-title":"Determination of hyperforin in human plasma using solid-phase extraction and high-performance liquid chromatography with ultraviolet detection.","volume":"780","author":"Cui","year":"2002","journal-title":"J Chromatogr B"},{"key":"10.1124\/dmd.32.1.28_bib14","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1067\/mcp.2000.112240","article-title":"St. John\u2019s wort induces intestinal P-glycoprotein\/MDR1 and intestinal and hepatic CYP3A4.","volume":"68","author":"D\u00fcrr","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.32.1.28_bib15","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1124\/dmd.30.1.96","article-title":"A pharmacophore for human pregnane X receptor ligands.","volume":"30","author":"Ekins","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.32.1.28_bib16","series-title":"Microsomes and Drug Oxidations","first-page":"95","article-title":"Organization of the microsomal electron transport system","author":"Estabrook","year":"1969"},{"key":"10.1124\/dmd.32.1.28_bib17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0031-6997(25)00021-3","article-title":"The molecular biology of cytochrome P450s.","volume":"40","author":"Gonzalez","year":"1989","journal-title":"Pharmacol Rev"},{"key":"10.1124\/dmd.32.1.28_bib18","first-page":"2969","article-title":"Pregnenolone 16 alpha-carbonitrile-inducible P-450 gene family: gene conversion and differential regulation.","volume":"6","author":"Gonzalez","year":"1986","journal-title":"Mol Cell Biol"},{"key":"10.1124\/dmd.32.1.28_bib19","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s002130000625","article-title":"St. John\u2019s wort (Hypericum perforatum): a review of the current pharmacological, toxicological and clinical literature.","volume":"153","author":"Greeson","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1124\/dmd.32.1.28_bib20","doi-asserted-by":"crossref","first-page":"7870","DOI":"10.1021\/ja00231a044","article-title":"Clean TOCSY for proton spin system identification in macromolecules.","volume":"110","author":"Griesinger","year":"1988","journal-title":"J Am Chem Soc"},{"key":"10.1124\/dmd.32.1.28_bib21","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1067\/mcp.2002.126913","article-title":"Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans.","volume":"72","author":"Gurley","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.32.1.28_bib22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1023\/A:1026702615125","article-title":"Regulation of phenobarbital-induction of CYP2B and CYP3A genes in rat cultured hepatocytes: involvement of several serine\/threonine protein kinases and phosphatases.","volume":"16","author":"Joannard","year":"2000","journal-title":"Cell Biol Toxicol"},{"key":"10.1124\/dmd.32.1.28_bib23","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1053\/cp.1999.v66.a101944","article-title":"Pharmacokinetic interaction of digoxin with an herbal extract from St. John\u2019s wort (Hypericum perforatum).","volume":"66","author":"Johne","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.32.1.28_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-291X(80)90695-6","article-title":"A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules.","volume":"95","author":"Kumar","year":"1980","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.32.1.28_bib25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0021-9673(00)00555-0","article-title":"Evaluation of major active components in St. John\u2019s wort dietary supplements by high-performance liquid chromatography with photodiode array detection and electrospray mass spectrometric confirmation.","volume":"888","author":"Liu","year":"2000","journal-title":"J Chromatogr A"},{"key":"10.1124\/dmd.32.1.28_bib26","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1006\/abbi.1994.1453","article-title":"Structure of a gene and cDNA of a major constitutive form of testosterone 6 beta-hydroxylase (P450\/6 beta A) encoding CYP3A2: comparison of the cDNA with P450PCN2.","volume":"314","author":"Miyata","year":"1994","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.32.1.28_bib27","doi-asserted-by":"crossref","first-page":"7500","DOI":"10.1073\/pnas.130155097","article-title":"St. John\u2019s wort induces hepatic drug metabolism through activation of the pregnane X receptor.","volume":"97","author":"Moore","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.32.1.28_bib28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1043-6618(02)00266-9","article-title":"Current St. John\u2019s wort research from mode of action to clinical efficacy.","volume":"47","author":"M\u00fcller","year":"2003","journal-title":"Pharmacol Res"},{"key":"10.1124\/dmd.32.1.28_bib29","first-page":"129","article-title":"Hyperforin represents the neurotransmitter reuptake inhibiting constituent of Hypericum perforatum L.","volume":"30","author":"M\u00fcller","year":"1998","journal-title":"Pharmacopsychiatry"},{"key":"10.1124\/dmd.32.1.28_bib30","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/sj.mp.4000557","article-title":"The experimental and clinical pharmacology of St. John\u2019s wort (Hypericum perforatum L.).","volume":"4","author":"Nathan","year":"1999","journal-title":"Mol Psychiatry"},{"key":"10.1124\/dmd.32.1.28_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00008571-199602000-00002","article-title":"P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.","volume":"6","author":"Nelson","year":"1996","journal-title":"Pharmacogenetics"},{"key":"10.1124\/dmd.32.1.28_bib32","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0022-3565(24)39043-3","article-title":"Inhibition of human cytochrome P450 enzymes by constituents of St. John\u2019s wort, an herbal preparation used in the treatment of depression.","volume":"294","author":"Obach","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.32.1.28_bib33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1211\/0022357991772132","article-title":"Isolation, purity analysis and stability of hyperforin as a standard material from Hypericum perforatum L.","volume":"51","author":"Orth","year":"1999","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/dmd.32.1.28_bib34","first-page":"60","article-title":"Stability and stabilization of hyperforin.","volume":"62","author":"Orth","year":"2000","journal-title":"Pharm Ind"},{"key":"10.1124\/dmd.32.1.28_bib35","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(99)05712-8","article-title":"Indinavir concentration and St. John\u2019s wort.","volume":"355","author":"Piscitelli","year":"2000","journal-title":"Lancet"},{"key":"10.1124\/dmd.32.1.28_bib36","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1067\/mcp.2000.106793","article-title":"St. John\u2019s wort: effect on CYP3A4 activity.","volume":"67","author":"Roby","year":"2000","journal-title":"Clin Pharmarcol Ther"},{"key":"10.1124\/dmd.32.1.28_bib37","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0031-9422(97)00903-5","article-title":"Oxidation products of hyperforin from Hypericum perforatum.","volume":"49","author":"Trifunovic","year":"1998","journal-title":"Phytochemistry"},{"key":"10.1124\/dmd.32.1.28_bib38","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1021\/np0105681","article-title":"Synthesis and biological evaluation of hyperforin analogues. (Part I). Modification of the enolized cyclohexanedione moiety.","volume":"64","author":"Verotta","year":"2002","journal-title":"J Nat Prod"},{"key":"10.1124\/dmd.32.1.28_bib39","doi-asserted-by":"crossref","first-page":"9688","DOI":"10.1021\/ja00025a053","article-title":"Gradient-enhanced HMQC and HSQC spectroscopy. Applications to 15N-labeled Mnt repressor.","volume":"113","author":"Vuister","year":"1991","journal-title":"J Am Chem Soc"},{"key":"10.1124\/dmd.32.1.28_bib40","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1042\/bj2810577","article-title":"Phenobarbital induction of cytochrome P-450 gene expression.","volume":"281","author":"Waxman","year":"1992","journal-title":"Biochem J"},{"key":"10.1124\/dmd.32.1.28_bib41","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1677\/joe.0.166r011","article-title":"St John\u2019s wort, a herbal antidepressant, activates the steroid X receptor.","volume":"166","author":"Wentworth","year":"2000","journal-title":"J Endocrinol"},{"key":"10.1124\/dmd.32.1.28_bib42","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00004850-200109000-00001","article-title":"A systematic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical review.","volume":"16","author":"Whiskey","year":"2001","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1124\/dmd.32.1.28_bib43","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0140-6736(05)73227-X","article-title":"Safety of St. John\u2019s wort (Hypericum perforatum).","volume":"355","author":"Yue","year":"2000","journal-title":"Lancet"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624028290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624028290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.32.1.28","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:32:48Z","timestamp":1739896368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624028290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0090955624028290"],"URL":"https:\/\/doi.org\/10.1124\/dmd.32.1.28","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IN VITRO METABOLISM OF HYPERFORIN IN RAT LIVER MICROSOMAL SYSTEMS","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.32.1.28","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2004 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}